Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Brianna L. Norton"'
Autor:
Snehal S. Lopes, Irene Pericot-Valverde, Paula J. Lum, Lynn E. Taylor, Shruti H. Mehta, Judith I. Tsui, Judith Feinberg, Arthur Y. Kim, Brianna L. Norton, Kimberly Page, Cristina Murray-Krezan, Jessica Anderson, Alison Karasz, Julia Arnsten, Phillip Moschella, Moonseong Heo, Alain H. Litwin
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Self-reported adherence to direct-acting antivirals (DAAs) to treat hepatitis C virus (HCV) among persons who inject drugs (PWID) is often an overreport of objectively measured adherence. The association of such overreporting with
Externí odkaz:
https://doaj.org/article/9c336d8dbf30498a87f9f33fc5063a19
Autor:
Akhila Padi, Irene Pericot-Valverde, Moonseong Heo, James Edward Dotherow, Jiajing Niu, Madhuri Martin, Brianna L. Norton, Matthew J. Akiyama, Julia H. Arnsten, Alain H. Litwin
Publikováno v:
Viruses, Vol 16, Iss 8, p 1304 (2024)
This study is a secondary analysis of a randomized clinical trial (October 2013–April 2017) involving 150 People Who Inject Drugs (PWIDs) with hepatitis C virus (HCV) seen in opioid agonist treatment programs in the Bronx, New York, and investigate
Externí odkaz:
https://doaj.org/article/b8b6d4f5e09b45e9ac2824b63d48dd80
Autor:
Irene Pericot-Valverde, Moonseong Heo, Matthew J. Akiyama, Brianna L. Norton, Linda Agyemang, Jiajing Niu, Alain H. Litwin
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Cigarette smoking has emerged as a leading cause of mortality among people with hepatitis C virus (HCV). People who inject drugs (PWID) represent the largest group of adults infected with HCV in the US. However, cigarette smoking
Externí odkaz:
https://doaj.org/article/b0009318ba7f4d9d87e8f177c727f352
Autor:
Matthew J. Akiyama, Linda Agyemang, Julia H. Arnsten, Moonseong Heo, Brianna L. Norton, Bruce R. Schackman, Benjamin P. Linas, Alain H. Litwin
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background People who inject drugs (PWID) constitute 60% of the approximately 5 million people in the U.S. infected with hepatitis C virus (HCV). Treatment of PWID is complex due to addiction, mental illness, poverty, homelessness, lack of p
Externí odkaz:
https://doaj.org/article/1a761fd3692346e5bf685d5de4e6d989
Autor:
Alain H. Litwin, Julia H. Arnsten, Hadi J Minhas, Moonseong Heo, Matthew J. Akiyama, Brianna L. Norton
Publikováno v:
AIDS care. 34(10)
Among people who inject drugs (PWID), 60% have HCV and 50-90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact
Autor:
Alain H Litwin, Paula J Lum, Lynn E Taylor, Shruti H Mehta, Judith I Tsui, Judith Feinberg, Arthur Y Kim, Brianna L Norton, Moonseong Heo, Julia Arnsten, Paul Meissner, Alison Karasz, M Diane Mckee, John W Ward, Nirah Johnson, Irene Pericot-Valverde, Linda Agyemang, Ellen S Stein, Aurielle Thomas, Courtney Borsuk, Kendra L Blalock, Samuel Wilkinson, Katherine Wagner, Jillian Roche, Cristina Murray-Krezan, Jessica Anderson, Vanessa Jacobsohn, Anne F Luetkemeyer, Oluwaseun Falade-Nwulia, Kimberly Page
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:1112-1127
To achieve WHO targets for the elimination of hepatitis C virus (HCV) as a public threat, an increased uptake of HCV treatment among people who inject drugs (PWID) is urgently needed. Optimal HCV co-located treatment models for PWID have not yet been
Autor:
Moonseong Heo, Irene Pericot‐Valverde, Jiajing Niu, Brianna L. Norton, Matthew J. Akiyama, Shadi Nahvi, Julia H. Arnsten, Alain H. Litwin
Publikováno v:
Journal of Viral Hepatitis. 30:172-175
Autor:
Madhuri Martin, Prerana J. Roth, Jiajing Niu, Irene Pericot‐Valverde, Moonseong Heo, Akhila Padi, Brianna L. Norton, Matthew J. Akiyama, Alain H. Litwin
Publikováno v:
Journal of Viral Hepatitis. 29:1004-1014
People who inject drugs (PWID) are a vulnerable population at high risk for acquiring hepatitis C virus (HCV) and frequently suffer from comorbid alcohol use. This study examines the characteristics and correlates of alcohol use among study participa
Autor:
Noah F. Markewitz, Joeseph DeLuca, Ayoola Kalejaiye, Sarah Shidid, Tanim Jain, Priyal Parikh, Brianna L. Norton
Publikováno v:
Annals of Internal Medicine: Clinical Cases. 2
Autor:
Jason Grebely, Gregory J. Dore, Frederick L. Altice, Brian Conway, Alain H. Litwin, Brianna L. Norton, Olav Dalgard, Edward J. Gane, Oren Shibolet, Ronald Nahass, Anne F. Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M. Kelly, Peggy Hwang, Ernest Asante-Appiah, Barbara A. Haber, Eliav Barr, Michael N. Robertson, Heather Platt
Publikováno v:
Annals of internal medicine. 175(9)
Hepatitis C virus (HCV) reinfection after successful treatment may reduce the benefits of cure among people who inject drugs.To evaluate the rate of HCV reinfection for 3 years after successful treatment among people receiving opioid agonist therapy